Clinical Trials supply Hope For Bone Marrow Cancer Patients

November 22nd, 2007 | Category: Cancer

Findings from two large, universal clinical trials show “unprecedented” survival for patients with multiple myeloma, a blood cancer that occurs in the blood-making cells of bone marrow. The findings demonstrate that with Revlimid, an oral cancer drug, all measures of

myeloma showed significant improvement in patients where previous treatments had folded. Rush University Medical Center took part in the U.S. study. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Oral Drug Sets New Survival Standard For Bone Marrow Cancer
  • Vidacare Announces Clearance Of Novel Bone Marrow Biopsy System For Hematology/Oncology
  • European Medicines Agency Recommends The Approval Of Thalidomide For The Treatment Of Rare Bone-Marrow Cancer
  • New Program At Huntsman Cancer Institute Can Offer More Years To Patients Afflicted With Myeloma
  • The universal Myeloma Foundation Identifies Potential Link within Genetic Pathways And Environmental Risks For Myeloma

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.